We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Ambarella
AMBA
$3.64B
| – | – |
-29,703
| Closed | -$3.12M |
|
2177
Aemetis
AMTX
$121M
| – | – |
-10,496
| Closed | -$133K |
|
2178
AnaptysBio
ANAB
$1.64B
| – | – |
-38,833
| Closed | -$961K |
|
2179
ANI Pharmaceuticals
ANIP
$1.74B
| – | – |
-28,738
| Closed | -$808K |
|
2180
Array Technologies
ARRY
$821M
| – | – |
-65,645
| Closed | -$740K |
|
2181
Asana
ASAN
$2.13B
| – | – |
-32,480
| Closed | -$1.3M |
|
|
CVSA
2182
Covista Inc
CVSA
$4.5B
| – | – |
-11,111
| Closed | -$330K |
|
2183
Atara Biotherapeutics
ATRA
$76.6M
| – | – |
-1,336
| Closed | -$310K |
|
2184
Mission Produce
AVO
$1.16B
| – | – |
-14,614
| Closed | -$185K |
|
2185
Axogen
AXGN
$2.6B
| – | – |
-11,983
| Closed | -$95K |
|
2186
AXT Inc
AXTI
$4.91B
| – | – |
-10,163
| Closed | -$71K |
|
2187
Azenta
AZTA
$1.54B
| – | – |
-2,438
| Closed | -$202K |
|
2188
BGC Group
BGC
$4.86B
| – | – |
-16,381
| Closed | -$72K |
|
2189
B&G Foods
BGS
$275M
| – | – |
-8,032
| Closed | -$217K |
|
2190
BILL Holdings
BILL
$4.9B
| – | – |
-7,663
| Closed | -$1.74M |
|
|
BPMC
2191
DELISTED
Blueprint Medicines
BPMC
| – | – |
-22,827
| Closed | -$1.46M |
|
2192
Cars.com
CARS
$653M
| – | – |
-16,017
| Closed | -$231K |
|
2193
Cameco
CCJ
$42.6B
| – | – |
-8,660
| Closed | -$252K |
|
2194
Cogent Communications
CCOI
$529M
| – | – |
-3,073
| Closed | -$204K |
|
2195
Coeur Mining
CDE
$18.7B
| – | – |
-36,953
| Closed | -$164K |
|
2196
CareDx
CDNA
$2.47B
| – | – |
-22,771
| Closed | -$842K |
|
2197
Cinemark Holdings
CNK
$4.35B
| – | – |
-10,475
| Closed | -$181K |
|
2198
Coursera
COUR
$1.53B
| – | – |
-9,239
| Closed | -$213K |
|
2199
Cerence
CRNC
$398M
| – | – |
-67,990
| Closed | -$2.45M |
|
2200
Citi Trends
CTRN
$622M
| – | – |
-26,707
| Closed | -$818K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.